Imaging News and Research

RSS

COST Connect: A platform for collaboration and progress in cancer research

Beating cancer is a major challenge for research and innovation in the coming years. By 2030, it is estimated that over 1.5 million people in the EU will succumb to cancer.

6 Jul 2023

OCT imaging method can improve diagnosis of multiple sclerosis

A study conducted by researchers from the Department of Neurology at MedUni Vienna and University Hospital Vienna has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye.

6 Jul 2023

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced updates to its flagship platform, Cyto-Mine®, enabling it to be compliant with current Good Manufacturing Practice (cGMP) regulations enforced by the US FDA.

From Fluidic Sciences and Sphere Bio 6 Jul 2023

New study to evaluate bleeding complications in patients undergoing high-risk PCI with Impella

A new multicenter, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice.

5 Jul 2023

Robotic system may accelerate studies in diverse areas of C. elegans biology

A robotic system capable of imaging and transferring the model organism Caenorhabditis elegans could replace hours of tedious lab work, according to a recent study.

5 Jul 2023

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Anti-amyloid immunotherapies for Alzheimer's disease require thorough evaluation of their efficacy, safety, and cost-effectiveness. Key questions regarding statistical analyses, treatment effects, and disease course modification guide evidence-based consideration of these drugs.

4 Jul 2023

EPFL scientists develop an innovative method for reconstructing Tau fibrils

EPFL scientists have developed ClearTau, an innovative method and platform for reconstructing aggregates of the protein Tau found in Alzheimer's disease and other neurodegenerative diseases.

4 Jul 2023

New biomarker for major depressive disorder identified

In appearance, the human brain's outermost layer, called the cortex, is a maze of tissue folds. The peaks or raised surfaces of these folds, called gyri, play an important role in the proper functioning of the brain.

4 Jul 2023

Menopausal hormone therapy associated with increased rate of dementia and Alzheimer's disease

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today.

3 Jul 2023

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), using an automated deep-learning AI tool, as well as weight-based volumetric thresholds, might afford large-scale evaluation for splenomegaly on CT examinations performed for any indication.

3 Jul 2023

Deep learning model could help identify high-risk patients with community-acquired pneumonia

According to an accepted manuscript published in ARRS' own American Journal of Roentgenology (AJR), a deep learning-based model using initial chest radiographs predicted 30-day mortality in patients with community-acquired pneumonia (CAP), improving upon the performance of an established risk prediction tool (i.e., CURB-65 score).

30 Jun 2023

AEM systematic review provides new insights into head imaging abnormalities in patients with acute delirium

Older adults who come to the Emergency Department (ED) with altered mental status (AMS), delirium, or confusion are more likely to have an acutely abnormal finding on computed tomography (CT) if they have a focal neurological deficit.

30 Jun 2023

20 years later: lessons from SARS-CoV-2 inform preparedness against future pandemics

The identification, development, and assessment of medical countermeasures against emerging pathogens.

30 Jun 2023

Research sheds light on genetic variants' impact beyond autism diagnosis

Scientists conducted the largest meta-analysis to elucidate the phenotypes of ASD-diagnosed individuals .

30 Jun 2023

Scientists visualize dynamic motion of gene regions on chromosomes

Despite being densely packed to fit into the nucleus, chromosomes storing our genetic information are always in motion.

29 Jun 2023

Using the power of machine learning to develop a predictive model of rumination

Our minds often get trapped in repetitive thoughts, such as past mistakes, regrets, insecurities, or unresolved conflicts.

29 Jun 2023

Non-invasive technique can help identify infants at high risk for retinopathy of prematurity

Research from Ann & Robert H. Lurie Children's Hospital of Chicago promises to spare many premature infants from undergoing invasive eye exams to detect retinopathy of prematurity (ROP), the most common cause of preventable lifelong blindness in children in the U.S.

29 Jun 2023

Study shows promising prospects for automating 3D-DSRT in drug testing

The June 2023 issue of SLAS Discovery contains one review article, five full-length articles and two technical briefs covering spheroid models, 3D cell high-throughput screening (HTS) applications for treating Alzheimer's and other drug discovery research.

29 Jun 2023

Use of menopausal hormone therapy associated with increased rate of dementia and Alzheimer's

Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer's disease, suggests a large Danish study published by The BMJ today.

28 Jun 2023

Glioblastoma cells found to have ‘critical point’ between order and disorder

Glioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clinical trials, the tumor's survival rate has remained stagnant.

28 Jun 2023

Imaging News and Research

COST Connect: A platform for collaboration and progress in cancer research

OCT imaging method can improve diagnosis of multiple sclerosis

Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows

New study to evaluate bleeding complications in patients undergoing high-risk PCI with Impella

Robotic system may accelerate studies in diverse areas of C. elegans biology

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

EPFL scientists develop an innovative method for reconstructing Tau fibrils

New biomarker for major depressive disorder identified

Menopausal hormone therapy associated with increased rate of dementia and Alzheimer's disease

Using AI might afford large-scale evaluation for splenomegaly on CT examinations

Deep learning model could help identify high-risk patients with community-acquired pneumonia

AEM systematic review provides new insights into head imaging abnormalities in patients with acute delirium

20 years later: lessons from SARS-CoV-2 inform preparedness against future pandemics

Research sheds light on genetic variants' impact beyond autism diagnosis

Scientists visualize dynamic motion of gene regions on chromosomes

Using the power of machine learning to develop a predictive model of rumination

Non-invasive technique can help identify infants at high risk for retinopathy of prematurity

Study shows promising prospects for automating 3D-DSRT in drug testing

Use of menopausal hormone therapy associated with increased rate of dementia and Alzheimer's

Glioblastoma cells found to have ‘critical point’ between order and disorder

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News